3004.90.92.46/Bupropion HCl XL 150mg Tablets/Japan

Bupropion HCl XL 150mg Tablets from Japan

Bupropion hydrochloride extended-release 150mg tablets treat depression and smoking cessation as atypical antidepressants. Classified under HTS 3004.90.92.46 for psychotherapeutic agents in measured retail doses affecting the central nervous system.

Duty Rate — Japan → United States

15%

Rate breakdown

9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate

9903.05.860%Universal product exemption (U.S. note 52(b))

9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)

Calculate with your customs value Verify classification with AI

Import Tips

• Provide seizure risk labeling and contraindication information per FDA

• Ensure 24-hour release profile documentation for XL formulations

• Batch testing for NDMA impurities required under current FDA guidance